cell-therapy

Documents about cell-therapy

• Nose-to-Brain Delivery of mRNA-Loaded Lipid Nanoparticles Bypasses the Blood–Brain Barrier for Effective Brain Disease Therapy#202131Figshare
• Mesenchymal stromal cells in the regeneration of radiation-induced organ sequelae: will they make the difference?#235182HAL (France)
• Carbon dot based topical application for therapy of phosphorus oxide-induced cutaneous burns#262034HAL (France)
• Modeling, Analysis, and Optimal Control of Leukemic Cell Population Dynamics Under Therapy#330181HAL (France)
• Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium#370791HAL (France)
• Investigating the protective effects of exercise in cardiotoxic cancer therapy#475602Figshare
• Design and evaluation of a novel peptide-EV complex for targeted Alzheimer’s disease therapy#478479Figshare
• Engineered T cells achieve durable persistence in the brain by clearing a state-selective checkpoint that governs neuroimmune privilege#651690eScholarship
• Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC#811108ClinicalTrials.gov
• Randomized Control Trial (RCT) of Early Palliative Care for HCC#828328ClinicalTrials.gov
• Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy#839928ClinicalTrials.gov
• SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN#864406ClinicalTrials.gov
• Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)#226862HAL (France)
• Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC#123475ClinicalTrials.gov
• CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery#307322ClinicalTrials.gov
• Integration of single-cell cis-expression quantitative trait locus and Mendelian randomization analyses identifies a Treg-specific gene for precision therapy in rheumatoid arthritis, gonarthrosis, and gouty arthritis.#320581NCBI PubMed Central
• PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy#347883HAL (France)
• Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer#356470ClinicalTrials.gov
• HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancer#377974HAL (France)
• Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy#460089ClinicalTrials.gov
• A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors#832218ClinicalTrials.gov
• CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL#857628ClinicalTrials.gov
• A Study of DeTIL-0255 in Adults With Advanced Malignancies#859743ClinicalTrials.gov
• A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)#839456ClinicalTrials.gov
• Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)#290969ClinicalTrials.gov
• Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)#803624ClinicalTrials.gov
• Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer#825854ClinicalTrials.gov
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3#813434ClinicalTrials.gov
• Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study#127610ClinicalTrials.gov
• Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant#407722ClinicalTrials.gov
• The Dual Role of Autophagy in Crizotinib-Treated ALK+ ALCL: From the Lymphoma Cells Drug Resistance to Their Demise#213230HAL (France)
• Are the Immune Properties of Mesenchymal Stem Cells from Wharton’s Jelly Maintained during Chondrogenic Differentiation?#239118HAL (France)
• Recommendations for the management of MPS IVA : systematic evidence- and consensus-based guidance#372699University of Pretoria Repository
• GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults#394743ClinicalTrials.gov
• CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia#417542ClinicalTrials.gov
• Comparison of experimental and radiobiological model-predicted survival of human laryngeal squamous cell carcinoma cells in a helium spread-out Bragg peak#482531HAL (France)
• Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer#800701ClinicalTrials.gov
• Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain#845464ClinicalTrials.gov
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer#851424ClinicalTrials.gov
• De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer#683089ClinicalTrials.gov
• CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy#834572ClinicalTrials.gov
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma#841974ClinicalTrials.gov
• PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy#184828ClinicalTrials.gov
• A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).#208336ClinicalTrials.gov
• Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer#229635Figshare
• Remodeling memory T cells with chemotherapy and immune checkpoint inhibitors as host pre-conditioning to empower in vivo CAR-T therapy#253510Europe PMC
• An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)#290975ClinicalTrials.gov
• A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia#435738ClinicalTrials.gov
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma#451527ClinicalTrials.gov
• Table 1_The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development.docx#471743Figshare